EyePoint Pharmaceuticals

SEC Filing Details

Document Details

Form
Filing Date
Jan 16, 2020
Document Date
Jan 13, 2020
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
EyePoint Pharmaceuticals
Issuer
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals